AEON Biopharma AEON
AEON Biopharma: preliminary proxy statement
- Form
- PRE 14A
- Filed
- Importance
- Routine
- Accession
- 0001104659-22-126386
Not explained yet; the original is on EDGAR.
Preliminary proxy statement
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- GT Biopharma GTBP public float $9M, Jun 30, 2025
- Biovie BIVI public float $8M, Dec 31, 2025
- TherapeuticsMD TXMD public float $9M, Jun 30, 2025
- Oncotelic Therapeutics OTLC public float $9M, Jun 30, 2025
- Talphera TLPH public float $8M, Jun 30, 2025